Health Canada

Health Canada has notified VDF FutureCeuticals, Inc., that it has no objection to the sale of Coffeeberry® whole coffee fruit derivatives as ingredients for use in foods and beverages sold in Canada. The Department conducted a comprehensive assessment of these products according to its Guidelines...

Bayer CropScience has developed cotton event GHB119 to be tolerant to glufosinate ammonium herbicides and resistant to lepidopteran pests. Recombinant DNA techniques were used to confer tolerance to the herbicide and impart pest resistance.

Health Canada has notified Renaissance BioScience Corporation that it has no objection to the food use of acrylamide-reducing baker's yeast, RBSC AR. The Department conducted a comprehensive assessment of this baker's yeast according to its Guidelines for the Safety Assessment of Novel Foods.

Health Canada has notified AquaBounty Canada Inc. that it has no objection to the food use of AquAdvantage salmon (AAS). The Department conducted a comprehensive assessment of this fish according to the Codex Alimentarius Guideline for the Conduct of Food Safety Assessment of Foods Derived from...

Health Canada has notified Okanagan Specialty Fruits Inc. that it has no objection to the food use of Arctic Apple events GD743 (Golden Delicious (GD) variety) and GS784 (Granny Smith (GS) variety). The Department conducted a comprehensive assessment of these varieties according to its Guidelines...

This report presents evidence-informed recommendations for testing a vaccinated population and vaccinated individuals.

The tables below list the COVID-19-related clinical trials which have been authorized by Health Canada through the Food and Drug Regulations or the Interim order No. 2 for clinical trials for medical devices and drugs related to COVID-19.

Learn more about drugs and vaccines being developed or authorized for COVID-19.

The Regulations Amending Certain Regulations Concerning Drugs and Medical Devices (Shortages) were made on September 1st, 2021. They amend the Food and Drug Regulations and Medical Devices Regulations and are published in Canada Gazette, Part II.

Phase I-III clinical trials involving natural health products on human subjects must be authorized by Health Canada's Natural and Non-prescription Health Products Directorate (NNHPD) before commencement of the trial.

This labelling standard describes the requirements necessary to receive market authorization (a Drug Identification Number (DIN)) for oral stool softener laxative non-prescription products containing docusate sodium or docusate calcium as a single ingredient for use in adults and children 6 years...

This Labelling Standard describes the requirements necessary to receive marketing authorization (a Drug Identification Number (DIN)) for single and multiple-ingredient orally administered nonprescription paediatric products for use in children 6 to under 12 years of age to provide relief of...

Companies that use unacceptable quality standards may be subject to enforcement action. Our main goal is to protect the health and safety of the public.

The Drug Facts Table provides a standardized format and location (on the label) for important product information. This helps consumers find and compare information quickly and easily.

The Natural Health Products Regulations (the Regulations) require all homeopathic medicines to have a licence before being sold in Canada. Licence holders are issued a product number which must appear on the label of their product. The product number for homeopathic medicines is preceded by DIN-HM.

This document describes how Health Canada's Health Products and Food Branch (HPFB) interprets the flexibility allowing for the use of a URL on Category IV products, mouthwash and toothpaste as described in the Good Label and Package Practices Guide for Non-prescription Drugs and Natural Health...

Answers from Health Canada to frequently asked questions regarding natural health products; some content intended for specific audiences

Frequently Asked Questions - Natural Health Products Regulations. This document is an unofficial summary of the Regulations.

The Drug Facts Table for Non-prescription Drugs Guidance Document gives direction for designing safe and clear labels and packages.

This guidance document is designed to assist organizations and individuals in applying for authorization to conduct a clinical trial for a natural health product (NHP) in Canada .